This study aims to explore the possibility of the existence of dyslipidemia among prediabetics in India and to find the correlation if any, present between their glycated hemoglobin (HbA1c) levels and their lipid profile, and to identify the risk factor(s) if any, for the onset of diabetes. A cross-sectional study involving 212 individuals in Bangalore of Karnataka State, India from the period of August 2017 to February 2019 was considered for the study. Within the lipid profile, High-Density Lipoprotein (HDL) and the ratio of cholesterol to HDL displayed statistically significant differences between the means of the population of healthy nondiabetics and prediabetics. In prediabetics, HbA1c was negatively correlated with HDL. so, testing of HDL and cholesterol to HDL ratio at regular intervals for prediabetics should be made mandatory, as they fall in the risk category for developing type 2 Diabetes and this regular screening of HDL and Cholesterol to HDL ratio will prevent prediabetics from progressing into type2 diabetes later on. Regarding demographic factors, abdominal obesity was found to be statistically significantly associated with prediabetes. Hence prediabetics should follow a regular exercise regime to prevent themselves from progressing into diabetes in their later years.
Introduction: Type II diabetes is a chronic disease which results from aspects such as complex inheritance interaction, obesity, and sedentary lifestyle. In India, diabetes is turning into an epidemic as currently, more than 62 million individuals suffer from the disease. To our knowledge, very few studies have evaluated the correlation between lipid profiles and glycated hemoglobin (HbA1c) in newly diagnosed type II diabetes patients with hypertension. The early detection of lipid abnormalities in these patients will help prevent the cardiovascular outcomes. Objectives: To identify patterns of dyslipidemia among newly diagnosed type II diabetes mellitus (DM) patients with and without hypertension in Bengaluru (urban and rural) in Karnataka (South India); and to identify correlations between HbA1c levels and lipid profiles. Methods: This was a cross sectional study involving 194 individuals in Bengaluru, India from the period of April to December 2017. Demographics, lifestyle habits and clinical features were analyzed for the presence of any interrelationship with the occurrence of diabetic dyslipidemia. One-way analysis of variance (ANOVA), followed by Tukey's post hoc tests, Chi square and correlation studies were used to establish a significant level of association between the study parameters. Results: Among non-diabetics, prediabetics, diabetics and diabetics with hypertension, there were significant differences in lipid profiles, as well as levels total cholesterol, triglycerides, high density lipoprotein (HDL), low density lipoprotein (LDL), very low-density lipoprotein, ratios of cholesterol to HDL and ratios of LDL to HDL. Positive correlations were observed between HbA1c and fasting blood sugar (FBS), and random blood sugar (RBS) in non-diabetics; whereas, in prediabetics, the RBS highly correlated with HbA1c and negatively correlated with HDL. In diabetics, both fasting and random blood sugar highly correlated with HbA1c, however, no significant correlation was observed between HbA1c and any of the tested lipid profiles in non-diabetics and diabetics. A strong correlation between HbA1c and lipid profiles was established. Conclusion: An overweight diabetic man with poor glycaemic control, over the age of 46 years, having a desk job or working as a driver or businessman, with abdominal obesity, leading a sedentary lifestyle and having habits such as alcohol drinking and smoking is at high risk for developing hypertension.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.